Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Xiao, Jian-Hui  [Clear All Filters]
2019
Luo Y, Cheng Y-W, Yu C-Y, Liu R-M, Zhao Y-J, Chen D-X, Zhong J-J, Xiao J-H. Effects of hyaluronic acid on differentiation of human amniotic epithelial cells and cell-replacement therapy in type 1 diabetic mice. Exp Cell Res. 2019:111642.
Wang Y-Q, Wang N-X, Luo Y, Yu C-Y, Xiao J-H. Ganoderal A effectively induces osteogenic differentiation of human amniotic mesenchymal stem cells via cross-talk between Wnt/β-catenin and BMP/SMAD signaling pathways. Biomed Pharmacother. 2019;123:109807.
2020
Wang A-T, Zhang Q-F, Wang N-X, Yu C-Y, Liu R-M, Luo Y, Zhao Y-J, Xiao J-H. Cocktail of Hyaluronic Acid and Human Amniotic Mesenchymal Cells Effectively Repairs Cartilage Injuries in Sodium Iodoacetate-Induced Osteoarthritis Rats. Front Bioeng Biotechnol. 2020;8:87.
2022
Cheng Y-W, Luo Y, Zheng S-J, Xiao J-H. Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment. Scand J Immunol. 2022:e13246.
Xing Y, Zhang M-S, Xiao J-H, Liu R-M. Galangin induces the osteogenic differentiation of human amniotic mesenchymal stem cells via the JAK2/STAT3 signaling pathway. Eur J Pharmacol. 2022:175326.
2023
Xu Y, Wang A-T, Xiao J-H. CD44 mediates hyaluronan to promote the differentiation of human amniotic mesenchymal stem cells into chondrocytes. Biotechnol Lett. 2023.
Luo Y, Xiao J-H. Inflammatory auxo-action in the stem cell division theory of cancer. PeerJ. 2023;11:e15444.
Wang W-H, You L-L, Huang K-Z, Li Z-J, Hu Y-X, Gu S-M, Li Y-Q, Xiao J-H. A nomogram model for predicting ocular GVHD following allo-HSCT based on risk factors. BMC Ophthalmol. 2023;23(1):28.
Fan S-X, Wang W-H, Zeng P, Huang K-Z, Hu Y-X, Wang J, Li Y-Q, Xiao J-H. Ocular manifestations and quality of life in patients after hematopoietic stem cell transplantation. Int J Ophthalmol. 2023;16(7):1138-1144.
Zheng S-J, Luo Y, Bin Wang J-, Chen X-M, Xu Y, Xiao J-H. Regulated intestinal microbiota and gut immunity to ameliorate type 1 diabetes mellitus: A novel mechanism for stem cell-based therapy. Biomed Pharmacother. 2023;170:116033.